Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    "fish-eye disease" OR "LCATA deficiency" OR "alpha-LCAT deficiency" OR "alpha-lecithin:cholesterol acyltransferase deficiency" OR "dyslipoproteinemic corneal dystrophy"
Show Display Options
Rank Status Study
1 Recruiting Mendelian Reverse Cholesterol Transport Study
Conditions: Cholesterol, HDL;   Lipid Metabolism, Inborn Errors;   Tangier Disease;   LCAT Deficiency;   CETP Deficiency
Intervention: Drug: 3H-cholesterol bound to albumin
2 Completed Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease
Conditions: Coronary Artery Disease;   Atherosclerosis
Intervention: Drug: ACP-501

Indicates status has not been verified in more than two years